Suncare Traders (539526)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at ₹1.29 against book value of ₹1.58, giving a P/B of 0.82 and a theoretical discount to stated assets
• Trailing P/E of 9.18 looks inexpensive, though earnings are collapsing
• Small market cap of ₹34 Cr leaves room for a focused, nimble investor if a real catalyst emerges
• Recent price of ₹1.29 is at the top of the 52-week range, showing some market interest

Concerns

• Sales growth down 71.43% and profit growth down 63.16%; latest quarter shows ₹0 Cr sales and ₹0 Cr profit
• ROE is negative at -0.20% and ROCE is only 2.28%, indicating poor use of capital
• Piotroski F-Score of 3/9 signals weak financial health and possible asset impairment
• No dividend and no promoter holding disclosure reduce transparency and shareholder returns

AI Analysis

Let me begin with the one number that initially catches my eye: the stock trades at ₹1.29 against a book value of ₹1.58, a price-to-book of 0.82. In the Graham tradition, buying a rupee of assets for 82 paise offers a margin of safety if those assets are genuine and recoverable. But the rest of this picture gives me little comfort. Suncare Traders is a trading and distribution business, and such businesses rarely have durable moats. The latest quarter shows sales of ₹0 Cr and net profit of ₹0 Cr, while sales growth has collapsed by 71.43% and profit growth by 63.16%. This is not a temporarily sleepy enterprise; it looks like a business that has stopped functioning. Return on equity is -0.20%, and ROCE is a feeble 2.28%, so the assets are not earning anything close to an acceptable return. The Piotroski F-Score of 3/9 reinforces the concern that the financial health is poor. The P/E of 9.18 may look superficially cheap, but with profits shrinking and the latest quarter at zero, trailing earnings are not a reliable guide to future earnings. There is no dividend, and promoter holding is not disclosed, which leaves me uncomfortable about transparency and alignment. I do not need extraordinary vision to see that this is a poor business selling at a cheap-looking price. It may be an asset play if the stated book value is solid and real, but negative ROE and a weak F-Score warn that book value could be impaired. I would not buy this today; I would only study it further as a possible deep-value liquidation situation.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer